Leptin levels in the differential diagnosis between benign and malignant ascites

Table 2 Ascitic leptin, TNFα and serum leptin levels in study population (mean ± SD)

	Controlsubjects	Cirrhoticpatients	Malignantascites	Tuberculousperitonitis
Leptin (ascites) (μg/L)	-	7.19 ± 3.43	2.45 ± 1.25	5.59 ± 1.08
Leptin (serum) (μg/L)	2.93 ± 0.32	3.77 ± 2.04	1.30 ± 0.63	3.72 ± 0.64
TNFα (ascites) (ng/L)	-	30.36 ± 6.37	29.65 ± 7.08	65.5 ± 18.4
Total proteins (ascites) (g/L)	-	15.4 ± 6.3	26.1 ± 11.5	28.2 ± 21.9
Albumin (ascites) (g/L)	-	7.1 ± 4.0	14.3 ± 7.2	13 ± 11.6
LDH (ascites) (U/L)	-	142.97 ± 93.99	546.5 ± 473.8	351.40 ± 378.82
Glucose (ascites) (mg/L)	-	1253.6 ± 348.1	1057.2 ± 443.8	1176 ± 482.3
Total leukocyte (ascites) ( × 106/L)	-	0.43 ± 0.46	976 ± 608.4	1.16 ± 1.17
Neutrophils (ascites) ( × 106/L)	-	0.22 ± 0.31	668.19 ± 416.3	0.44 ± 0.63
Lymphocytes (ascites) ( × 106/L)	-	0.12 ± 0.01	223.34 ± 102.3	0.75 ± 0.32